Biochip Segmentation for Multiplex DNA Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current DNA detection methods in integrated biochips, such as capillary electrophoresis and microarray technology, face limitations in multiplexing capabilities due to size constraints and non-specific amplification issues, requiring expensive optics and being limited to detecting fewer DNA fragments, whereas traditional qPCR systems are cost-effective but restricted to fewer color detections.

Innovation Solution

A functionally integrated biochip with multiple separation and detection chambers, each containing unique DNA probes, allows for space separation and detection of DNA fragments, enabling the use of low-cost qPCR optics while increasing fragment detection capability by several folds, and includes features like universal Luer taper-type connectors for quick reagent connection and a closed system with integrated reagent cartridges.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If capillary electrophoresis or mass spectroscopy is used for DNA fragment detection, then multiple DNA fragments can be detected, but the DNA fragments must be of unique sizes larger than the separation resolution and expensive optics are required

Engineering Contradiction:
Improvenumber of DNA fragments detectedVSAvoidseparation resolution requirements and optics cost
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The detection system is segmented into multiple independent detection chambers, each capable of detecting DNA fragments with a specific fluorophore. This allows parallel detection of multiple DNA fragments without requiring size-based separation, eliminating the need for expensive optics and complex separation resolution while increasing the number of detectable DNA fragments

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention transitions from size-based detection (one dimension) to fluorophore-based detection (another dimension). By detecting DNA fragments based on their fluorescent labels rather than size, the system can simultaneously detect multiple fragments of similar sizes using different fluorophores, thereby increasing detection capacity without requiring expensive separation optics

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Measurement precision

If qPCR with TaqMan probe method is used, then detection specificity is improved, but the number of DNA fragments detectable is limited by the number of color detections

Engineering Contradiction:
Improvedetection specificityVSAvoidnumber of DNA fragments detected
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The system divides the detection function into multiple independent detection chambers, each optimized for a specific fluorophore. This segmentation allows the system to maintain the high specificity of qPCR probe-based detection while expanding the total number of detectable DNA fragments by distributing different probe-fluorophore combinations across multiple chambers

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Each detection chamber is designed to be universal for its assigned fluorophore, accommodating multiple DNA fragment targets that share the same fluorophore label. This multi-functionality allows a single chamber to detect multiple DNA fragments simultaneously, thereby increasing the total detection capacity beyond the limitation of color-based detection

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Productivity

If multiplex PCR or isothermal amplification is used, then the ability to amplify several DNA fragments is improved, but non-specific amplification interference increases when DNA fragments are similar in size

Engineering Contradiction:
Improvenumber of DNA fragments amplifiedVSAvoiddiscrimination of non-specific amplification
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The invention shifts the discrimination dimension from size-based separation to fluorophore-based identification. By assigning unique fluorophores to different DNA fragment targets, the system can reliably distinguish between specific and non-specific amplification products even when they have similar sizes, thereby maintaining high productivity while improving reliability

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Data Source

PatentUS9132426B2Simplified gating method for sealing and flow control in micro and nano devices
Publication Date: 2015.09.15 NANOMDX INC
  • US9132426B2 patent drawing
  • US9132426B2 patent drawing
  • US9132426B2 patent drawing

AI summary

A biochip for multiplex genetic identification is disclosed. An biochip for separating and detecting a plurality of DNA fragments includes a set of inputs and chambers for receiving a sample matrix of genetic material and reagents needed to conduct a polymerase chain reaction amplification of the genetic material. The biochip also includes a plurality of separation and detection chambers that physically separate different DNA fragments that have been marked with labels that emit similar colors, thereby enabling the independent detection of the different DNA fragments.